Dr. Hendrik Wolff

Prof. Dr. med. Hendrik Wolff is a renowned specialist in Radiation Therapy, Radiation Oncology, and Palliative Care, with extensive experience in various academic and clinical settings. He is currently serving as the Shareholder and the Head of Radiation Therapy at Radiologie München in Germany, as well as the Head of Radiation Therapy and the "Munich Support Center" at the Schwabing Clinic in Munich, Germany. Prior to these roles, Prof. Dr. med. Wolff held several positions at the Department... of Radiation Therapy and Radiation Oncology of the University Hospital Göttingen in Germany, including the Deputy Director and the Managing Senior Physician. Prof. Dr. med. Wolff has been affiliated with several professional organizations, including the European Society for Radiotherapy and Oncology, the Society for Biological Radiation Research, and the German Society for Radiation Oncology. He has also served as a reviewer for several prominent journals in the field, including "Radiotherapy and Oncology," "Radiation Oncology," "IJROBP," "Radiation Therapy and Oncology," "Acta Oncologica," and "BMC Cancer." Prof. Dr. med. Wolff has received several awards for his contributions to the field, including the Elekta Poster Prize and the Varian Poster Prize from the German Society for Radiation Oncology, and the Isodose Control Prize from the Society for Biological Radiation Research. He has published more than 100 papers on various aspects of radiation therapy and oncology, making him a recognized authority in the field. Prof. Dr. med. Wolff's scientific works since the license to teach was granted include: Various planning studies on the correlation of radiotherapy technology to acute and chronic side effects and the therapy outcome, Research on the importance of different gene variants in the treatment of rectal ca, Investigation of the importance of various clinical and tumor-specific parameters in rectal ca, Development of a score/size classification in the hyperthermia treatment of breast cancer recurrences, Investigation of various clinical and biological factors in the treatment of ENT tumors, Investigations on the correlation of therapy-associated side effects and outcome parameters in different tumor entities, Acute effect of radiation on cardiomyocytes, Studies on the treatment of nasopharynx Ca including the governing body of the GPOH-NPC study group, Supervision and successful completion of 20 doctoral theses.